Skip to main content

Table 1 Clinical characteristics in HCM patients and controls

From: Diastolic dysfunction assessed by cardiac magnetic resonance imaging tissue tracking on normal-thickness wall segments in hypertrophic cardiomyopathy

Parameter

Controls (n = 30)

Patients (n = 63)

p-value

Age (year)

50 ± 11

54 ± 11

0.07

Sex, male (%)

18 (60.0)

43 (68.3)

0.06

Height (m)

1.65 ± 0.07

1.66 ± 0.07

0.42

Weight (kg)

67.7 ± 12.2

68.1 ± 12.1

0.87

BMI (kg/m2)

24.8 ± 4.3

24.4 ± 3.0

0.65

BSA (m2)

1.72 ± 0.18

1.73 ± 0.19

0.75

Heart rate (beats/min)

66 (60, 76)

68 (63, 74)

0.38

Systolic BP (mm Hg)

120 (112, 128)

125 (118, 135)

0.06

Diastolic BP (mm Hg)

80 (73, 82)

80 (71, 88)

0.61

Drinking (%)

4 (13.3)

7 (11.1)

0.79

Smoking (%)

5 (16.7)

17 (27.0)

0.56

Hct (%)

40.9 ± 4.7

40.4 ± 4.7

0.38

  1. The values are presented as frequencies (percentages) or means ± standard deviation or medians (interquartile range)
  2. HCM, hypertrophic cardiomyopathy; BMI, body mass index; BSA, body surface area; BP, blood pressure; Hct, hematocrit